Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3

BACKGROUND: The genes of SPARC, CCR2, and SMAD3 are implicated in orchestrating inflammatory response that leads to fibrosis in scleroderma and other fibrotic disorders. The aim of the studies is to evaluate synergistic anti-fibrotic potency of the siRNAs of these genes. METHODS: The efficacy of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Weifeng, Pu, Weilin, Jiang, Shuai, Ma, Yanyun, Liu, Qingmei, Wu, Wenyu, Chu, Haiyan, Zou, Hejian, Jin, Li, Wang, Jiucun, Zhou, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306344/
https://www.ncbi.nlm.nih.gov/pubmed/30470612
http://dx.doi.org/10.1016/j.ebiom.2018.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306344/
https://www.ncbi.nlm.nih.gov/pubmed/30470612
http://dx.doi.org/10.1016/j.ebiom.2018.11.016

Ejemplares similares